UPDATE: [Close of Comments on Commerce Cyber Rule]
Client Alert | 1 min read | 01.20.22
On January 12, 2022 the U.S. Department of Commerce’s Bureau of Industry and Security (BIS) issued a federal register notice delaying the effective date of new controls on cybersecurity items and an accompanying new license exception. The rules are now set to take effect on March 7, 2022.
The new controls were published in an interim final rule on October 21, 2021, please see our earlier client alert on this. Broadly speaking, they cover (a) items, including software, for the generation, command and control, or delivery of intrusion software and (b) internet protocol (IP) network communication surveillance equipment. BIS delayed the implementation to give industry additional time to comply with the new restrictions as well as update internal compliance procedures, and to provide BIS itself time to provide additional guidance on the rule. BIS may also consider some modifications to the rule, but is not reopening the comment period and these modifications based on the latest comments will most likely be made, if at all, sometime after the new effective date for the interim final rule.
Contacts
Associate
She/Her/Hers
Associate
She/Her/Hers
Insights
Client Alert | 14 min read | 05.03.24
On April 24, 2024, President Biden signed into law the National Security Supplemental fiscal package, which includes significant new sanctions and export controls authorities. Although the U.S. foreign aid commitments for Ukraine, Israel, and Taiwan headline the new law, it also (1) expands the statute of limitations for U.S. sanctions violations; (2) includes new authorities for the President to coordinate sanctions efforts with the European Union and the United Kingdom; (3) expands sanctions and export controls on Iran (including some targeted at Chinese financial institutions); and (4) includes new sanctions authorities targeting terror groups.
Client Alert | 3 min read | 05.03.24
EEOC’s New “Enforcement Guidance on Harassment in the Workplace” Hits Hot-Button Issues
Client Alert | 11 min read | 05.03.24
FDA Moves Forward on Laboratory Developed Tests while Stakeholders and Congress Weigh Next Steps
Client Alert | 1 min read | 05.03.24
